nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ADORA1—Aminophylline—chronic obstructive pulmonary disease	0.273	0.399	CbGbCtD
Mefloquine—ADORA2A—Aminophylline—chronic obstructive pulmonary disease	0.241	0.353	CbGbCtD
Mefloquine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0249	0.0365	CbGbCtD
Mefloquine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0249	0.0365	CbGbCtD
Mefloquine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0222	0.0325	CbGbCtD
Mefloquine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0209	0.0306	CbGbCtD
Mefloquine—HBA2—leg—chronic obstructive pulmonary disease	0.0189	0.301	CbGeAlD
Mefloquine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0141	0.0207	CbGbCtD
Mefloquine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0135	0.0197	CbGbCtD
Mefloquine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.012	0.0176	CbGbCtD
Mefloquine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0118	0.0172	CbGbCtD
Mefloquine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0111	0.0162	CbGbCtD
Mefloquine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.00901	0.144	CbGeAlD
Mefloquine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00704	0.0103	CbGbCtD
Mefloquine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00665	0.00973	CbGbCtD
Mefloquine—HBA1—respiratory system—chronic obstructive pulmonary disease	0.0051	0.0813	CbGeAlD
Mefloquine—HBA2—respiratory system—chronic obstructive pulmonary disease	0.00469	0.0747	CbGeAlD
Mefloquine—HBA1—connective tissue—chronic obstructive pulmonary disease	0.00449	0.0716	CbGeAlD
Mefloquine—HBA2—connective tissue—chronic obstructive pulmonary disease	0.00412	0.0657	CbGeAlD
Mefloquine—HBA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00377	0.0601	CbGeAlD
Mefloquine—HBA1—lung—chronic obstructive pulmonary disease	0.00271	0.0432	CbGeAlD
Mefloquine—HBA2—lung—chronic obstructive pulmonary disease	0.00249	0.0396	CbGeAlD
Mefloquine—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.00126	0.02	CbGeAlD
Mefloquine—ADORA1—lung—chronic obstructive pulmonary disease	0.00112	0.0178	CbGeAlD
Mefloquine—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00103	0.0164	CbGeAlD
Mefloquine—BCHE—bronchus—chronic obstructive pulmonary disease	0.000846	0.0135	CbGeAlD
Mefloquine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000828	0.0132	CbGeAlD
Mefloquine—BCHE—trachea—chronic obstructive pulmonary disease	0.00076	0.0121	CbGeAlD
Mefloquine—BCHE—lung—chronic obstructive pulmonary disease	0.000546	0.0087	CbGeAlD
Mefloquine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00049	0.00781	CbGeAlD
Mefloquine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000362	0.00577	CbGeAlD
Mefloquine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000295	0.0019	CcSEcCtD
Mefloquine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.0019	CcSEcCtD
Mefloquine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000295	0.0019	CcSEcCtD
Mefloquine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.0019	CcSEcCtD
Mefloquine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000295	0.0019	CcSEcCtD
Mefloquine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000294	0.0019	CcSEcCtD
Mefloquine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.0019	CcSEcCtD
Mefloquine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000294	0.0019	CcSEcCtD
Mefloquine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00189	CcSEcCtD
Mefloquine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00189	CcSEcCtD
Mefloquine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00189	CcSEcCtD
Mefloquine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00189	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00189	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00189	CcSEcCtD
Mefloquine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00189	CcSEcCtD
Mefloquine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00188	CcSEcCtD
Mefloquine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00188	CcSEcCtD
Mefloquine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00186	CcSEcCtD
Mefloquine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00186	CcSEcCtD
Mefloquine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000289	0.00186	CcSEcCtD
Mefloquine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00186	CcSEcCtD
Mefloquine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00185	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00185	CcSEcCtD
Mefloquine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000286	0.00185	CcSEcCtD
Mefloquine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00182	CcSEcCtD
Mefloquine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00182	CcSEcCtD
Mefloquine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00182	CcSEcCtD
Mefloquine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00182	CcSEcCtD
Mefloquine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00182	CcSEcCtD
Mefloquine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.0018	CcSEcCtD
Mefloquine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.0018	CcSEcCtD
Mefloquine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.0018	CcSEcCtD
Mefloquine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00179	CcSEcCtD
Mefloquine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00179	CcSEcCtD
Mefloquine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00179	CcSEcCtD
Mefloquine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00179	CcSEcCtD
Mefloquine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00179	CcSEcCtD
Mefloquine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00179	CcSEcCtD
Mefloquine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00179	CcSEcCtD
Mefloquine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00178	CcSEcCtD
Mefloquine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00178	CcSEcCtD
Mefloquine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00177	CcSEcCtD
Mefloquine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00177	CcSEcCtD
Mefloquine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00177	CcSEcCtD
Mefloquine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00177	CcSEcCtD
Mefloquine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.00176	CcSEcCtD
Mefloquine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00175	CcSEcCtD
Mefloquine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000271	0.00175	CcSEcCtD
Mefloquine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00173	CcSEcCtD
Mefloquine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00172	CcSEcCtD
Mefloquine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00172	CcSEcCtD
Mefloquine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000264	0.0017	CcSEcCtD
Mefloquine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.0017	CcSEcCtD
Mefloquine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00169	CcSEcCtD
Mefloquine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00169	CcSEcCtD
Mefloquine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00169	CcSEcCtD
Mefloquine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00168	CcSEcCtD
Mefloquine—ABCB1—lung—chronic obstructive pulmonary disease	0.00026	0.00415	CbGeAlD
Mefloquine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00167	CcSEcCtD
Mefloquine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.00166	CcSEcCtD
Mefloquine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00166	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00166	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00166	CcSEcCtD
Mefloquine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00165	CcSEcCtD
Mefloquine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00165	CcSEcCtD
Mefloquine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00164	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00163	CcSEcCtD
Mefloquine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00163	CcSEcCtD
Mefloquine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00163	CcSEcCtD
Mefloquine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00162	CcSEcCtD
Mefloquine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00162	CcSEcCtD
Mefloquine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00161	CcSEcCtD
Mefloquine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00161	CcSEcCtD
Mefloquine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000249	0.0016	CcSEcCtD
Mefloquine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.0016	CcSEcCtD
Mefloquine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000249	0.0016	CcSEcCtD
Mefloquine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.0016	CcSEcCtD
Mefloquine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00159	CcSEcCtD
Mefloquine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.00158	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00157	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00157	CcSEcCtD
Mefloquine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00157	CcSEcCtD
Mefloquine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00157	CcSEcCtD
Mefloquine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00157	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00157	CcSEcCtD
Mefloquine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00156	CcSEcCtD
Mefloquine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00155	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00154	CcSEcCtD
Mefloquine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00154	CcSEcCtD
Mefloquine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00153	CcSEcCtD
Mefloquine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00153	CcSEcCtD
Mefloquine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00152	CcSEcCtD
Mefloquine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.00152	CcSEcCtD
Mefloquine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00152	CcSEcCtD
Mefloquine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00151	CcSEcCtD
Mefloquine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00151	CcSEcCtD
Mefloquine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.0015	CcSEcCtD
Mefloquine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000233	0.0015	CcSEcCtD
Mefloquine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000233	0.0015	CcSEcCtD
Mefloquine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.0015	CcSEcCtD
Mefloquine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00149	CcSEcCtD
Mefloquine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00149	CcSEcCtD
Mefloquine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00149	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00149	CcSEcCtD
Mefloquine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00148	CcSEcCtD
Mefloquine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000226	0.00146	CcSEcCtD
Mefloquine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00145	CcSEcCtD
Mefloquine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00145	CcSEcCtD
Mefloquine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Mefloquine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Mefloquine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Mefloquine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Mefloquine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Mefloquine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00144	CcSEcCtD
Mefloquine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00143	CcSEcCtD
Mefloquine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Mefloquine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Mefloquine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000221	0.00142	CcSEcCtD
Mefloquine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00142	CcSEcCtD
Mefloquine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00142	CcSEcCtD
Mefloquine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.00142	CcSEcCtD
Mefloquine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00141	CcSEcCtD
Mefloquine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00141	CcSEcCtD
Mefloquine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00141	CcSEcCtD
Mefloquine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00141	CcSEcCtD
Mefloquine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00139	CcSEcCtD
Mefloquine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00138	CcSEcCtD
Mefloquine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00137	CcSEcCtD
Mefloquine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00136	CcSEcCtD
Mefloquine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00136	CcSEcCtD
Mefloquine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00134	CcSEcCtD
Mefloquine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00134	CcSEcCtD
Mefloquine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00134	CcSEcCtD
Mefloquine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00134	CcSEcCtD
Mefloquine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00132	CcSEcCtD
Mefloquine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00131	CcSEcCtD
Mefloquine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00131	CcSEcCtD
Mefloquine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00129	CcSEcCtD
Mefloquine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00129	CcSEcCtD
Mefloquine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00129	CcSEcCtD
Mefloquine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00128	CcSEcCtD
Mefloquine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00127	CcSEcCtD
Mefloquine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00126	CcSEcCtD
Mefloquine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00125	CcSEcCtD
Mefloquine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00125	CcSEcCtD
Mefloquine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00123	CcSEcCtD
Mefloquine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00122	CcSEcCtD
Mefloquine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00122	CcSEcCtD
Mefloquine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00121	CcSEcCtD
Mefloquine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00121	CcSEcCtD
Mefloquine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00121	CcSEcCtD
Mefloquine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00118	CcSEcCtD
Mefloquine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00118	CcSEcCtD
Mefloquine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00116	CcSEcCtD
Mefloquine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00116	CcSEcCtD
Mefloquine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00115	CcSEcCtD
Mefloquine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00115	CcSEcCtD
Mefloquine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00115	CcSEcCtD
Mefloquine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00115	CcSEcCtD
Mefloquine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00114	CcSEcCtD
Mefloquine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00114	CcSEcCtD
Mefloquine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00114	CcSEcCtD
Mefloquine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00114	CcSEcCtD
Mefloquine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00114	CcSEcCtD
Mefloquine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00113	CcSEcCtD
Mefloquine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00112	CcSEcCtD
Mefloquine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00112	CcSEcCtD
Mefloquine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00112	CcSEcCtD
Mefloquine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000171	0.0011	CcSEcCtD
Mefloquine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00109	CcSEcCtD
Mefloquine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00109	CcSEcCtD
Mefloquine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00109	CcSEcCtD
Mefloquine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00109	CcSEcCtD
Mefloquine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00108	CcSEcCtD
Mefloquine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00108	CcSEcCtD
Mefloquine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00108	CcSEcCtD
Mefloquine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00108	CcSEcCtD
Mefloquine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00108	CcSEcCtD
Mefloquine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00106	CcSEcCtD
Mefloquine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00106	CcSEcCtD
Mefloquine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00105	CcSEcCtD
Mefloquine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00104	CcSEcCtD
Mefloquine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00103	CcSEcCtD
Mefloquine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00102	CcSEcCtD
Mefloquine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00102	CcSEcCtD
Mefloquine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000156	0.001	CcSEcCtD
Mefloquine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000992	CcSEcCtD
Mefloquine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000987	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000987	CcSEcCtD
Mefloquine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000971	CcSEcCtD
Mefloquine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000964	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000954	CcSEcCtD
Mefloquine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000944	CcSEcCtD
Mefloquine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000937	CcSEcCtD
Mefloquine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000916	CcSEcCtD
Mefloquine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000893	CcSEcCtD
Mefloquine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000892	CcSEcCtD
Mefloquine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000886	CcSEcCtD
Mefloquine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000885	CcSEcCtD
Mefloquine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000879	CcSEcCtD
Mefloquine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000879	CcSEcCtD
Mefloquine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000828	CcSEcCtD
Mefloquine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000816	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000814	CcSEcCtD
Mefloquine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000808	CcSEcCtD
Mefloquine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000793	CcSEcCtD
Mefloquine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00079	CcSEcCtD
Mefloquine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000788	CcSEcCtD
Mefloquine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000784	CcSEcCtD
Mefloquine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000773	CcSEcCtD
Mefloquine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000762	CcSEcCtD
Mefloquine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000759	CcSEcCtD
Mefloquine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000748	CcSEcCtD
Mefloquine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000748	CcSEcCtD
Mefloquine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000746	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000743	CcSEcCtD
Mefloquine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000739	CcSEcCtD
Mefloquine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000727	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000717	CcSEcCtD
Mefloquine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000717	CcSEcCtD
Mefloquine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000706	CcSEcCtD
Mefloquine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000704	CcSEcCtD
Mefloquine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.0007	CcSEcCtD
Mefloquine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000697	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000694	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000654	CcSEcCtD
Mefloquine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000653	CcSEcCtD
Mefloquine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000649	CcSEcCtD
Mefloquine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000644	CcSEcCtD
Mefloquine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000631	CcSEcCtD
Mefloquine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000624	CcSEcCtD
Mefloquine—Rash—Prednisolone—chronic obstructive pulmonary disease	9.65e-05	0.000622	CcSEcCtD
Mefloquine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.64e-05	0.000622	CcSEcCtD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.61e-05	0.000972	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.6e-05	0.000971	CbGpPWpGaD
Mefloquine—Fatigue—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000619	CcSEcCtD
Mefloquine—Headache—Prednisolone—chronic obstructive pulmonary disease	9.59e-05	0.000618	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.41e-05	0.000951	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.35e-05	0.000945	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.29e-05	0.000939	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.28e-05	0.000938	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.24e-05	0.000934	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	9.19e-05	0.000929	CbGpPWpGaD
Mefloquine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000591	CcSEcCtD
Mefloquine—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	9.14e-05	0.000924	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000587	CcSEcCtD
Mefloquine—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.09e-05	0.000586	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.96e-05	0.000905	CbGpPWpGaD
Mefloquine—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.00057	CcSEcCtD
Mefloquine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000567	CcSEcCtD
Mefloquine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000567	CcSEcCtD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.78e-05	0.000887	CbGpPWpGaD
Mefloquine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.75e-05	0.000885	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ALB—chronic obstructive pulmonary disease	8.68e-05	0.000877	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	8.67e-05	0.000876	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	8.61e-05	0.00087	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	8.55e-05	0.000865	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.49e-05	0.000858	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	8.4e-05	0.000849	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.3e-05	0.000839	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.28e-05	0.000837	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.23e-05	0.000832	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.21e-05	0.00083	CbGpPWpGaD
Mefloquine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000529	CcSEcCtD
Mefloquine—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	8.16e-05	0.000824	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.13e-05	0.000822	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.12e-05	0.00082	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.02e-05	0.00081	CbGpPWpGaD
Mefloquine—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000515	CcSEcCtD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.9e-05	0.000798	CbGpPWpGaD
Mefloquine—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000508	CcSEcCtD
Mefloquine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.72e-05	0.00078	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.63e-05	0.000771	CbGpPWpGaD
Mefloquine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000491	CcSEcCtD
Mefloquine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000474	CcSEcCtD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.25e-05	0.000733	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.22e-05	0.00073	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.16e-05	0.000724	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.08e-05	0.000715	CbGpPWpGaD
Mefloquine—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000456	CcSEcCtD
Mefloquine—Rash—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000452	CcSEcCtD
Mefloquine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000452	CcSEcCtD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.98e-05	0.000706	CbGpPWpGaD
Mefloquine—Headache—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000449	CcSEcCtD
Mefloquine—Nausea—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000426	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.58e-05	0.000665	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ALB—chronic obstructive pulmonary disease	6.57e-05	0.000664	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.56e-05	0.000663	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.52e-05	0.000659	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.42e-05	0.000648	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.34e-05	0.000641	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.33e-05	0.00064	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.29e-05	0.000636	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.27e-05	0.000633	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.22e-05	0.000629	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.06e-05	0.000612	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.01e-05	0.000607	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.99e-05	0.000605	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	5.89e-05	0.000595	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.87e-05	0.000593	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.82e-05	0.000588	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	5.76e-05	0.000582	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.74e-05	0.00058	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.57e-05	0.000563	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.52e-05	0.000558	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.48e-05	0.000554	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.43e-05	0.000549	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	5.41e-05	0.000547	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.4e-05	0.000546	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.36e-05	0.000542	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.35e-05	0.000541	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.33e-05	0.000538	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.32e-05	0.000537	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.28e-05	0.000533	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.27e-05	0.000533	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	5.27e-05	0.000533	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	5.26e-05	0.000531	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.24e-05	0.00053	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	5.19e-05	0.000525	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.1e-05	0.000515	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.08e-05	0.000514	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.05e-05	0.00051	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.03e-05	0.000509	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.02e-05	0.000507	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.01e-05	0.000507	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.99e-05	0.000504	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.99e-05	0.000504	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.92e-05	0.000497	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.9e-05	0.000495	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.89e-05	0.000494	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.89e-05	0.000494	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.85e-05	0.00049	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.81e-05	0.000486	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.76e-05	0.000481	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	4.73e-05	0.000478	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	4.7e-05	0.000475	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.66e-05	0.000471	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.6e-05	0.000465	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.59e-05	0.000464	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.53e-05	0.000458	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.49e-05	0.000454	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.45e-05	0.000449	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.41e-05	0.000445	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.36e-05	0.000441	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.32e-05	0.000436	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	4.22e-05	0.000427	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.2e-05	0.000424	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.19e-05	0.000424	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.16e-05	0.000421	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.14e-05	0.000418	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.11e-05	0.000416	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.1e-05	0.000415	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.07e-05	0.000411	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.05e-05	0.000409	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.01e-05	0.000405	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.99e-05	0.000404	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.99e-05	0.000403	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.98e-05	0.000402	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.96e-05	0.000401	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.89e-05	0.000393	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.87e-05	0.000391	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.87e-05	0.000391	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.75e-05	0.000379	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.7e-05	0.000374	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.7e-05	0.000374	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.68e-05	0.000371	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.67e-05	0.000371	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.54e-05	0.000358	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.5e-05	0.000354	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.45e-05	0.000349	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.41e-05	0.000345	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	3.38e-05	0.000342	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	3.27e-05	0.000331	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.22e-05	0.000325	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.22e-05	0.000325	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.000325	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	3.18e-05	0.000322	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.17e-05	0.00032	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.15e-05	0.000318	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—chronic obstructive pulmonary disease	3.07e-05	0.00031	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.000308	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	3.02e-05	0.000305	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.000304	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.97e-05	0.0003	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.96e-05	0.000299	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.92e-05	0.000295	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	2.92e-05	0.000295	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	2.9e-05	0.000293	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.87e-05	0.00029	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	2.84e-05	0.000287	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.83e-05	0.000286	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.83e-05	0.000286	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.81e-05	0.000284	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.73e-05	0.000276	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-05	0.00027	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.67e-05	0.00027	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.65e-05	0.000267	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000266	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.63e-05	0.000266	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	2.59e-05	0.000262	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.57e-05	0.00026	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.56e-05	0.000259	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.56e-05	0.000258	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.48e-05	0.000251	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.46e-05	0.000249	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.000248	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.45e-05	0.000248	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.43e-05	0.000246	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.42e-05	0.000244	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.39e-05	0.000241	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.38e-05	0.000241	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.29e-05	0.000231	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.25e-05	0.000227	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.000225	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.2e-05	0.000222	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.19e-05	0.000221	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.17e-05	0.00022	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.17e-05	0.000219	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.13e-05	0.000215	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.000207	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.05e-05	0.000207	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.04e-05	0.000207	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.02e-05	0.000204	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.000201	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.99e-05	0.000201	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.97e-05	0.000199	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-05	0.000198	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.96e-05	0.000198	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.000196	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	1.94e-05	0.000196	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.92e-05	0.000194	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.9e-05	0.000192	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.00019	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.88e-05	0.00019	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.83e-05	0.000185	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.83e-05	0.000185	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.79e-05	0.000181	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000181	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.77e-05	0.000178	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000175	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.71e-05	0.000173	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.62e-05	0.000164	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.61e-05	0.000163	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.00016	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000154	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000148	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.000147	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.45e-05	0.000146	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000142	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.39e-05	0.00014	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.00014	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.37e-05	0.000139	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000134	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-05	0.000134	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.32e-05	0.000133	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000132	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.000128	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.000128	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.23e-05	0.000125	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.23e-05	0.000124	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000123	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.00012	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000119	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000119	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.000117	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.13e-05	0.000115	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.12e-05	0.000113	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000112	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000111	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.06e-05	0.000107	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.71e-06	9.81e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.58e-06	9.68e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.53e-06	9.63e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.33e-06	9.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.15e-06	9.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.03e-06	9.12e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.92e-06	9.02e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.75e-06	8.84e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.63e-06	8.72e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.58e-06	8.67e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.54e-06	8.63e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.53e-06	8.62e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.46e-06	8.55e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.41e-06	8.5e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.97e-06	8.06e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.79e-06	7.87e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.2e-06	7.28e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.17e-06	7.25e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.59e-06	6.66e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.98e-06	6.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.9e-06	5.96e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.75e-06	5.81e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.5e-06	5.56e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.5e-06	5.56e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.42e-06	5.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.21e-06	5.27e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.18e-06	5.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.54e-06	3.58e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.39e-06	3.43e-05	CbGpPWpGaD
